| TRAF6 is an amplified oncogene bridging the RAS and NF-kappaB pathways in human lung cancer. | lung, |
| Identified an alternative oncogenic pathway for TRAF6 that uses AEP as its substrate. AEP and TRAF6 protein levels may have prognostic implications in breast cancer patients. Thus, AEP may serve as a biomarker as well as new therapeutic target | breast, |
| TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. | None |
| NFkappaB signaling is induced by the oncoprotein Tio through direct interaction with TRAF6. | None |
| STP-A11, an oncoprotein of Herpesvirus saimiri augments both NF-kappaB and AP-1 transcription activity through TRAF6. | None |
| STP-C, an oncoprotein of herpesvirus saimiri augments the activation of NF-kappaB through ubiquitination of TRAF6. | None |
| Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1). | None |
| Roles of the kinase TAK1 in TRAF6-dependent signaling by CD40 and its oncogenic viral mimic, LMP1. | None |